콘텐츠로 건너뛰기
Merck
  • Prenatal diagnosis of Morquio disease type A using a simple fluorometric enzyme assay.

Prenatal diagnosis of Morquio disease type A using a simple fluorometric enzyme assay.

Prenatal diagnosis (1990-02-01)
H Zhao, O P Van Diggelen, R Thoomes, J Huijmans, E Young, T Mazurczak, W J Kleijer
초록

A new fluorogenic substrate, 4 methylumbelliferyl beta-D-6-sulphogalactoside, was used for the assay of galactose-6-sulphate sulphatase activity in chorionic villi, cultured villus cells, and amniocytes. The fluorometric assay is much more convenient than the conventional assay using radiolabelled, sulphated oligosaccharides. Both types of substrate were used in the prenatal diagnosis of three pregnancies at risk for Morquio type A disease using amniocytes. These enzyme tests, as well as electrophoresis of glycosaminoglycans in the amniotic fluid, indicated affected fetuses in two pregnancies and a non-affected fetus in one.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
4-Methylumbelliferyl β-D-galactopyranoside-6-sulfate sodium salt, ≥90% (HPLC)